✨ Medicines Act Notices
27 SEPTEMBER
NEW ZEALAND GAZETTE
3383
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Cimetidine
Active Ingredient(s):
Cimetidine 200mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada
Product:
Apo-Cimetidine
Active Ingredient(s):
Cimetidine 400mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada
Product:
Apo-Cimetidine
Active Ingredient(s):
Cimetidine 800mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada
Product:
Apo-Gliclazide
Active Ingredient(s):
Gliclazide 80mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Apotex Inc, Weston, Ontario, Canada
Product:
Probitor
Active Ingredient(s):
Omeprazole 20mg
Dosage Form:
Modified release capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Liconsa SA, Azuqueca de Henares, Guadalajara, Spain
Dated this 18th day of September 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go6684
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Ilomedin
Active Ingredient(s):
Iloprost trometamol 134µg/mL equivalent to 100µg Iloprost/mL
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Schering (NZ) Limited
Manufacturer(s):
Schering AG, Wedding Plant, Berlin, Germany
Product:
WinRho SDF
Active Ingredient(s):
Anti-D (Rho) immunoglobulin 600IU equivalent to 120µg
Dosage Form:
Powder for injection
New Zealand Sponsor:
CSL (New Zealand) Limited
Manufacturer(s):
Cangene Corporation, Winnipeg, Manitoba, Canada
Dated this 18th day of September 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go6685
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 132
Gazette.govt.nz —
NZ Gazette 2001, No 132
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare18 September 2001
Medicines Act 1981, New Medicines, Distribution Consent, Cimetidine, Gliclazide, Omeprazole
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare18 September 2001
Medicines Act 1981, Changed Medicines, Distribution Consent, Iloprost, Anti-D Immunoglobulin
- G. R. Boyd, Chief Advisor, Safety and Regulation